NXTC NextCure, Inc.

Provides biopharmaceutical new immuno oncology products.

As of 04/09/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/08/2019
Outstanding shares:  27,599,949
Average volume:  146,290
Market cap:   $265,511,509
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    65343E108
ISIN:        US65343E1082
Sedol:      BJL3CL5
Valuation   (See tab for details)
PE ratio:   27.28
PB ratio:   0.86
PS ratio:   11.86
Return on equity:   -12.46%
Net income %:   -163.57%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy